MIAMI (February 29, 2012) — International law firm McDermott Will & Emery LLP will gather leading private equity, investment banking, finance and healthcare company executives in Miami on Thursday, March 8th, for the annual McDermott 2012 Healthcare Services Private Equity Symposium.
The McDermott 2012 Healthcare Services Private Equity Symposium is the premier conference and networking event addressing critical business and legal issues specific to healthcare services private equity transactions. The conference presents a unique opportunity for healthcare companies who are considering partnering with a private equity firm to get exposure to and gain a better understanding of the investment strategies of some of the top private equity firms in the U.S. who are active investors in the healthcare space.
The conference is expected to attract more than 300 private equity principals, lenders financing private equity backed companies, investment bankers, C-level executives from all segments of the healthcare services sector and others with a vested interest in healthcare services private equity transactions.
“Private equity investment in healthcare services is at an all time high and the fever pitch continues,” said Ira J. Coleman, Health Industry Advisory Group partner at McDermott Will & Emery and program chair of the Healthcare Services Private Equity Symposium. “The biggest question today is how the Supreme Court’s opinion on the constitutionality of the Affordable Care Act will affect investment activity in this sector. We are excited to bring leading authorities together to discuss the possible outcomes as well as the opportunities and challenges of investing in healthcare services. McDermott’s health attorneys are constantly on the leading-edge of this fast-moving marketplace and are seeing first-hand how new investments are impacting the healthcare ecosystem.”
“This symposium is designed to give existing and potential investors an opportunity to reflect on their current investment strategies and, if necessary, make adjustments to take advantage of potential market opportunities,” said Laurence Bronska, partner and co-head of McDermott’s Private Equity practice. ”Over the life of this symposium, we have seen growing interest from private equity fund investors in this highly regulated space. With this increasing competition to deploy capital, it is more important than ever to be creative and place well considered bets. We are hopeful that this symposium serves as a means to that end.”
The McDermott symposium will be held at the JW Marriott Marquis Miami. For more information about the program and this year’s sponsors, please click here.
The private equity practice at McDermott Will & Emery is among the few, if any, law firms capable of offering the vital blend of in-depth private equity experience and highly focused industry knowledge. Health private equity lawyers advise leading private equity and venture capital firms, management teams and companies in the health industry on growth equity investments and venture financings, joint ventures, leveraged buyouts and recapitalizations, mergers and acquisitions, initial public offerings and other general corporate matters. McDermott is uniquely positioned to advise private equity funds that invest in healthcare services, medical devices and pharmaceuticals, health technologies and distressed opportunities. The Firm has been retained to act as deal counsel on some of the largest transactions in the healthcare sector to date. McDermott has also been retained as regulatory counsel, assisting private equity clients and their due diligence teams in quickly identifying healthcare regulatory issues, including healthcare fraud and abuse concerns, Medicare billing issues, healthcare privacy and security restrictions, and federal and state licensure issues.
With an over 30-year history of serving the healthcare industry, McDermott has one of the largest and most prestigious health practice groups in the world. Our international health team, resident in the Firm's Boston, Chicago, Los Angeles, Miami, Munich, New York, Rome, Silicon Valley and Washington, D.C. offices, counsels leading organizations in every major sector of the health and life sciences industry on regulatory and business transaction issues. McDermott is the only Firm to receive Tier 1 rankings in both Chambers USA and Legal 500 USA in 2011 for healthcare. In its 2010 and 2011 rankings, Chambers USA ranked the Firm's health practice as the only firm in Tier 1 in the United States. The Firm represents healthcare clients as either general or special counsel. Non-institutional clients include physicians and other health professionals on both an individual and group (such as medical staff or professional association) basis. Institutional clients include integrated delivery systems, hospitals, large physician group practices, physician and dental practice management companies, ambulatory care clients, nursing homes, visiting nurse associations, home health agencies, health maintenance organizations, and other forms of alternative delivery systems and hospices.
About McDermott Will & Emery
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, the Firm has offices in Boston, Brussels, Chicago, Düsseldorf, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Silicon Valley and Washington, D.C., and a close strategic alliance with MWE China Law Offices in Shanghai.